[Effect of treatment with erythropoietin (r-EPO) on hemodynamics of the cardiovascular system in patients with chronic renal failure (c.r.f.)]. 1994

A Kubasik, and A Debska-Slizień, and M Dudziak, and B Bułło, and B Rutkowski
Zakładu Diagnostyki Chorób Serca, Akademii Medycznej w Gdańsku.

Patients with chronic renal failure (c.r.f.) are at high risks of death from cardiovascular diseases. It was found that successful treatment of anemia could positively influence not only patients well being but also caused some unfavourable hemodynamic changes. The aim of the study was the estimation of some morphological and functional parameters of left ventricle (lv) in dialyzed and predialyzed patients treated with r-Epo. Two groups of patients with c.r.f. were studied. The I group of 10 dialyzed patients (6 W, 4 M, mean age 34 +/- 11, weight 55 +/- 9 kg), and the II group of 9 pre-dialyzed patients (6 W, 3 M, mean age 50.6 +/- 10, weight 63 +/- 14 kg). r-Epo (Eprex Cilag AG) was administered during 6 months s.c. The I group was given initial dose 3 x 2000 u per week (mean dose 24-46 u/kg b.w./per week, the II was on 3 x 2000 u per week (mean dose 24-46 u/kg b.w./per week) subcutaneously. The doses were adjusted by Hb level in order to keep it within limits (10-12 g/dl). Hematological parameters were monitored once a week by Technicon H1. Morphology and function of the lv were evaluated using echocardiographic measurements performed by Irex IIIA system. According to prescriptions of ASE the following parameters have been assessed: lv dimension, thickness of posterior wall in diastole and systole and thickness of interventricular septum in diastole.(ABSTRACT TRUNCATED AT 250 WORDS)

UI MeSH Term Description Entries
D007676 Kidney Failure, Chronic The end-stage of CHRONIC RENAL INSUFFICIENCY. It is characterized by the severe irreversible kidney damage (as measured by the level of PROTEINURIA) and the reduction in GLOMERULAR FILTRATION RATE to less than 15 ml per min (Kidney Foundation: Kidney Disease Outcome Quality Initiative, 2002). These patients generally require HEMODIALYSIS or KIDNEY TRANSPLANTATION. ESRD,End-Stage Renal Disease,Renal Disease, End-Stage,Renal Failure, Chronic,Renal Failure, End-Stage,Chronic Kidney Failure,End-Stage Kidney Disease,Chronic Renal Failure,Disease, End-Stage Kidney,Disease, End-Stage Renal,End Stage Kidney Disease,End Stage Renal Disease,End-Stage Renal Failure,Kidney Disease, End-Stage,Renal Disease, End Stage,Renal Failure, End Stage
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D002318 Cardiovascular Diseases Pathological conditions involving the CARDIOVASCULAR SYSTEM including the HEART; the BLOOD VESSELS; or the PERICARDIUM. Adverse Cardiac Event,Cardiac Events,Major Adverse Cardiac Events,Adverse Cardiac Events,Cardiac Event,Cardiac Event, Adverse,Cardiac Events, Adverse,Cardiovascular Disease,Disease, Cardiovascular,Event, Cardiac
D004921 Erythropoietin Glycoprotein hormone, secreted chiefly by the KIDNEY in the adult and the LIVER in the FETUS, that acts on erythroid stem cells of the BONE MARROW to stimulate proliferation and differentiation.
D005260 Female Females
D006352 Heart Ventricles The lower right and left chambers of the heart. The right ventricle pumps venous BLOOD into the LUNGS and the left ventricle pumps oxygenated blood into the systemic arterial circulation. Cardiac Ventricle,Cardiac Ventricles,Heart Ventricle,Left Ventricle,Right Ventricle,Left Ventricles,Right Ventricles,Ventricle, Cardiac,Ventricle, Heart,Ventricle, Left,Ventricle, Right,Ventricles, Cardiac,Ventricles, Heart,Ventricles, Left,Ventricles, Right
D006435 Renal Dialysis Therapy for the insufficient cleansing of the BLOOD by the kidneys based on dialysis and including hemodialysis, PERITONEAL DIALYSIS, and HEMODIAFILTRATION. Dialysis, Extracorporeal,Dialysis, Renal,Extracorporeal Dialysis,Hemodialysis,Dialyses, Extracorporeal,Dialyses, Renal,Extracorporeal Dialyses,Hemodialyses,Renal Dialyses
D006439 Hemodynamics The movement and the forces involved in the movement of the blood through the CARDIOVASCULAR SYSTEM. Hemodynamic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

A Kubasik, and A Debska-Slizień, and M Dudziak, and B Bułło, and B Rutkowski
June 1991, Polskie Archiwum Medycyny Wewnetrznej,
A Kubasik, and A Debska-Slizień, and M Dudziak, and B Bułło, and B Rutkowski
September 1994, Polskie Archiwum Medycyny Wewnetrznej,
A Kubasik, and A Debska-Slizień, and M Dudziak, and B Bułło, and B Rutkowski
January 1994, Annales Universitatis Mariae Curie-Sklodowska. Sectio D: Medicina,
A Kubasik, and A Debska-Slizień, and M Dudziak, and B Bułło, and B Rutkowski
January 1997, Polskie Archiwum Medycyny Wewnetrznej,
A Kubasik, and A Debska-Slizień, and M Dudziak, and B Bułło, and B Rutkowski
October 2003, Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego,
A Kubasik, and A Debska-Slizień, and M Dudziak, and B Bułło, and B Rutkowski
November 2010, Zhongguo zhen jiu = Chinese acupuncture & moxibustion,
A Kubasik, and A Debska-Slizień, and M Dudziak, and B Bułło, and B Rutkowski
January 2004, Terapevticheskii arkhiv,
A Kubasik, and A Debska-Slizień, and M Dudziak, and B Bułło, and B Rutkowski
February 2000, American journal of kidney diseases : the official journal of the National Kidney Foundation,
A Kubasik, and A Debska-Slizień, and M Dudziak, and B Bułło, and B Rutkowski
March 1994, Angiology,
A Kubasik, and A Debska-Slizień, and M Dudziak, and B Bułło, and B Rutkowski
January 1994, Clinical and experimental rheumatology,
Copied contents to your clipboard!